🏥 Despite women comprising 36% of physicians, surgical instruments have long been standardized for men’s hands. In an exclusive interview with Healio, Lara Devgan, MD, who created a line of plastic surgery instruments for women, speaks on this issue 👇 healio.com/news/dermatolo…

🚨 The FDA has approved a pediatric indication for Vericel® Corporation's NexoBrid for the treatment of deep partial-thickness and full-thickness thermal burns. Read more 👇 #dermtwitter #dermatology healio.com/news/dermatolo…

Your dermatology essentials are here! Healio News, CME, and Clinical Guidance are here to enhance your medical journey: bit.ly/4f1DWQ8

In the latest installment of Beneath the Surface, Joel M Gelfand MD MSCE FAAD and John E. Harris, MD, PhD discuss the expanding treatment landscape of #vitiligo including: 🔑 Treatment options 🔑 Timelines 🔑 Success rates 🔑 Patient expectations Check it out 👇 #dermtwitter healio.com/news/dermatolo…

Individuals with moderate to severe #psoriasis experience work absenteeism in the form of half days more than those with a mild form of the disease: 💼 Mild = 2.8 💼💼 Moderate to severe = 4.4 Read more on this study from SLU Medicine 👇 #dermnews healio.com/news/dermatolo…

🌱 Patients who followed a plant-based #diet experienced hair growth with the addition of a daily #vegan nutraceutical. Healio spoke with Isabelle Raymond, PhD, about the importance of these results and taking a "multi-modal approach" to #hairloss 👇 healio.com/news/dermatolo…

💉 Simone Biles said she is "so not doing that again" after receiving "baby Botox." In an exclusive Healio interview, David Hill, MD, speaks on the downsides of baby #Botox including: ▶️ Undertreatment ▶️ Muscle twitching ▶️ Slight asymmetry 👇 healio.com/news/dermatolo…

📣 It's been 9 months since the #FDA released recommended changes to the #iPledge REM Strategy, and providers are growing increasingly frustrated at a perceived lack of transparency and implementation plan. Experts, including John Barbieri, MD, MBA, weigh in 👇 healio.com/news/dermatolo…

Have a safe and happy #LaborDay! 💙 From your friends at #Healio ❤️

Most patients with chronic hand #eczema suffer from corticosteroid phobia, despite being unable to name risks: ▶️ 75.5% agreed topical corticosteroids (TCS) cause damage to skin ▶️ 36.3% reported being scared to use TCS but couldn't name risks healio.com/news/dermatolo…

☢️ Radiotherapy and hematopoietic cell transplant increased the risk for #keratinocytecarcinoma development in childhood #cancer survivors. Christina Boull, MD, of University of Minnesota, weighs in 👇 #dermtwitter healio.com/news/dermatolo…

Secukinumab was safe and efficacious in treating #psoriasis in patients with #skinofcolor: 🔑 73% of patients with skin of color achieved PASI 90 🔑 Patient-reported dyspigmentation and quality of life scores improved Read more 🔽 Journal of Drugs in Dermatology (JDD) healio.com/news/dermatolo…

🧴 The #FDA hasn't approved a new #sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why... and the answer is more complicated than you think. Experts weigh in here 👇 Heather D. Rogers MD Doctor Rogers Dr. Rossi DERM MD EWG #dermtwitter healio.com/news/dermatolo…

📣 The #FDA has granted rare pediatric disease designation to Cartesian Therapeutics's Descartes-08, an autologous mRNA cell therapy, for the treatment of juvenile #dermatomyositis. Read more 🔽 Healio Pulmonology Healio Rheumatology #dermtwitter healio.com/news/dermatolo…

💥 The cosmetic industry is preparing for yet another rapidly approaching deadline imposed by MoCRA and set for the end of this year. Learn more about this news with input from Jaclyn Bellomo, MS, MBA, of Registrar Corp, here 🔽 #dermtwitter healio.com/news/dermatolo…

Veterans experience higher prevalence rates of skin cancer, especially #melanoma, and #psoriasis compared with nonveterans, according to a study led by Shawheen J Rezaei from Stanford Medicine. Read more about these results here 👇 #veterans #dermtwitter healio.com/news/dermatolo…

Great article in Healio Dermatology today featuring our CMO! He discusses our recent #publication in Journal of Investigative Dermatology highlighting the central role of #IRAK4 signaling in inflammation in HS patients and the transformative potential of KT-474, our first-in-class IRAK4 degrader:

Continuing medical education is a journey—one filled with milestones, discoveries, and achievements. Whether you're just starting out or looking to advance further, we’re here to help you navigate your path, track your progress, and achieve your goals. shorturl.at/lk284

📢 Presented at #MenopauseSocietymth: ▶️ Female pattern #hairloss 💇is a common condition often experienced during #menopause, but options are available to reverse & regrow hair with prompt diagnosis and treatment. 👩‍🦳 The Menopause Society Healio Dermatology 👇 healio.com/news/womens-he…

🚨 The #FDA has approved Ebglyss for the treatment of moderate-to-severe atopic #dermatitis that is not well controlled with topical prescription therapies, Eli Lilly and Company announced in a press release 👇 Healio Allergy and Asthma #dermtwitter healio.com/news/dermatolo…